X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (175992) 175992
Publication (8702) 8702
Book Chapter (1414) 1414
Conference Proceeding (216) 216
Book Review (200) 200
Dissertation (43) 43
Presentation (8) 8
Paper (2) 2
Book / eBook (1) 1
Poster (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hematology, oncology and palliative medicine (175377) 175377
humans (68266) 68266
index medicus (61629) 61629
oncology (57863) 57863
female (38879) 38879
radiology (37734) 37734
cancer (31532) 31532
male (29457) 29457
middle aged (27767) 27767
aged (24253) 24253
hematology (23414) 23414
adult (21802) 21802
radiotherapy (17224) 17224
care and treatment (16657) 16657
surgery (14003) 14003
analysis (12855) 12855
chemotherapy (11993) 11993
radiology, nuclear medicine & medical imaging (11240) 11240
aged, 80 and over (11217) 11217
obstetrics and gynecology (10689) 10689
treatment outcome (10444) 10444
transplantation (9991) 9991
prognosis (9372) 9372
radiation (9007) 9007
breast cancer (8752) 8752
retrospective studies (8373) 8373
tumors (7979) 7979
animals (7432) 7432
article (7410) 7410
metastasis (7383) 7383
health aspects (7313) 7313
survival (6996) 6996
risk factors (6879) 6879
neoplasm staging (6724) 6724
pulmonary/respiratory (6548) 6548
research (6514) 6514
carcinoma (6413) 6413
therapy (6225) 6225
oncology, experimental (6062) 6062
obstetrics & gynecology (6061) 6061
radiology and nuclear medicine (6007) 6007
young adult (5833) 5833
adolescent (5720) 5720
internal medicine (5178) 5178
cancer patients (5142) 5142
antineoplastic combined chemotherapy protocols - therapeutic use (5010) 5010
disease-free survival (4970) 4970
patients (4826) 4826
expression (4488) 4488
antineoplastic agents - therapeutic use (4456) 4456
radiotherapy dosage (4401) 4401
medical colleges (4302) 4302
neoplasms (4226) 4226
stem cells (4158) 4158
prostate cancer (4105) 4105
cell line, tumor (4091) 4091
genetic aspects (4083) 4083
radiation-therapy (4057) 4057
risk (4035) 4035
diagnosis (3980) 3980
follow-up studies (3980) 3980
survival analysis (3969) 3969
clinical trials (3843) 3843
peripheral vascular disease (3843) 3843
survival rate (3811) 3811
prospective studies (3772) 3772
mortality (3764) 3764
mice (3740) 3740
medical research (3736) 3736
child (3718) 3718
patient outcomes (3715) 3715
apoptosis (3666) 3666
time factors (3649) 3649
lung cancer (3645) 3645
women (3583) 3583
lung cancer, non-small cell (3519) 3519
breast neoplasms - pathology (3462) 3462
otolaryngology (3401) 3401
antineoplastic agents (3367) 3367
ovarian cancer (3261) 3261
antimitotic agents (3250) 3250
lung neoplasms - pathology (3115) 3115
trial (3088) 3088
mutation (3004) 3004
breast-cancer (2956) 2956
respiratory system (2949) 2949
colorectal cancer (2874) 2874
hematopoietic stem cells (2874) 2874
diseases (2873) 2873
nuclear radiation (2836) 2836
medicine, experimental (2833) 2833
advanced basic science (2796) 2796
pharmacology & pharmacy (2787) 2787
radiation doses (2777) 2777
radioisotope brachytherapy (2761) 2761
immunology (2750) 2750
development and progression (2721) 2721
leukemia (2677) 2677
medicine, research & experimental (2668) 2668
toxicity (2662) 2662
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (177265) 177265
Spanish (109) 109
Polish (14) 14
French (10) 10
German (7) 7
Russian (4) 4
Chinese (3) 3
Italian (2) 2
Japanese (2) 2
Afrikaans (1) 1
Czech (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 954 - 965
Summary Background Addition of a MEK inhibitor to a BRAF inhibitor enhances tumour growth inhibition, delays acquired resistance, and abrogates paradoxical... 
Hematology, Oncology and Palliative Medicine
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 4, pp. 436 - 444
Summary Background The orally available BRAF kinase inhibitor vemurafenib, compared with dacarbazine, shows improved response rates, progression-free survival... 
Hematology, Oncology and Palliative Medicine
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 81, pp. 242 - 242
The authors regret that the name of the 9th author was misspelt in the original publication. The correct spelling is Begoña Mellado, as given above. The... 
Hematology, Oncology and Palliative Medicine
Journal Article
Hematology/oncology clinics of North America, 08/2019, Volume 33, Issue 4, p. xiii
Journal Article
Hematology/Oncology Clinics of North America, ISSN 0889-8588, 2019, Volume 33, Issue 3, p. xiii
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 75, pp. 308 - 309
Journal Article
Hematology/Oncology Clinics of North America, ISSN 0889-8588, 2019, Volume 33, Issue 2, p. xi
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 3, pp. e134 - e134
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 3, pp. e134 - e134
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 3, pp. 293 - 293
Journal Article
Cancer Letters, ISSN 0304-3835, 2017, Volume 398, pp. 22 - 23
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 2, pp. e65 - e65
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 584 - 584
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 4, pp. e233 - e233
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 72, pp. S10 - S10
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 72, pp. S120 - S120
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.